CClinicalTrials.gg
CompletedNCT02020018Updated Nov 6, 2019Results posted

Negative Pressure Wound Therapy for Prevention of Poststernotomy Infection

An interventional study of Prevena Incision Management System and Conventional sterile dry wound dressing in Surgical Wound Infection, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-11-06.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,869
Allocation
Non-randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

This prospective study evaluates the role of negative pressure wound therapy or wound VAC as a dressing over the incision to prevent poststernotomy wound infection in high risk patients.

Read the detailed description

Surgical site infection after cardiac surgery is a major cause for increased morbidity and mortality. Vacuum assisted closure (VAC) has been used in the management of open and infected wounds. However, its effectiveness as a prophylactic measure for prevention of surgical site infection after routine cardiac surgery is unknown.

02

Conditions studied

03

In context

Infections

6,687 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's enrollment of 1,869 is above the median of 120 across 4,200 interventional studies indexed under Infections.

Browse Infections studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Transplant patients
  2. BMI >30
  3. Type I (insulin-dependent) diabetics
  4. Severe chronic obstructive pulmonary disease (COPD)
  5. Steroid-dependent patients
  6. Previous Tracheostomy

Exclusion criteria

Exclusion criteria:

  1. BMI\<30
  2. Thoracotomy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,869 participants (actual)

Study arms

  • Experimental
    Prospective group

    Negative pressure wound therapy (Prevena Incision Management System) applied immediately postoperatively.

    Device: Prevena Incision Management System

  • Active comparator
    Retrospective arm

    Conventional sterile dry wound dressing applied immediately postoperatively.

    Other: Conventional sterile dry wound dressing

Interventions

  • DevicePrevena Incision Management System

    negative pressure therapy that will be applied instead of the regular dressing immediately postoperatively in high risk patients and kept for 6-7 days

    Also known as: negative pressure therapy, wound VAC, Prevena

  • OtherConventional sterile dry wound dressing

    regular dressing that is applied immediately postoperatively for high risk patients in the operating room after sternotomy

    Also known as: poststernotomy wound dressing, standard dressing after sternotomy

06

What researchers measure

Primary outcomes

  1. Wound Infection After Open Heart Surgery

    The total number of participants with surgical site infections after cardiac surgery.

    Time frame: 30 days post-surgery

Secondary outcomes

  1. Reoperation for Wound Infection

    The total number of reoperations required due to infection.

    Time frame: 30 days post surgery

Other outcomes

  1. Length of Stay

    Length of stay was defined as the number of nights spent in the hospital after surgery.

    Time frame: postoperative to discharge

07

Results

Posted Nov 6, 2019

Participant flow

Participant flow — Overall Study
MilestoneProspective GroupRetrospective Arm
Started2721597
Completed2721597
Not completed00

Outcome measures

PrimaryWound Infection After Open Heart Surgery

The total number of participants with surgical site infections after cardiac surgery.

Time frame:
30 days post-surgery
Reported as:
Count of participants · Participants
Wound Infection After Open Heart Surgery
ParticipantsProspective GroupRetrospective Arm
Wound Infection After Open Heart Surgery417
Statistical analysis
  • Prospective Group vs Retrospective Arm · Fisher Exact · p = 0.55
SecondaryReoperation for Wound Infection

The total number of reoperations required due to infection.

Time frame:
30 days post surgery

No measurements were reported for this outcome.

Other pre-specifiedLength of Stay

Length of stay was defined as the number of nights spent in the hospital after surgery.

Time frame:
postoperative to discharge

No measurements were reported for this outcome.

Adverse events

Collected over Adverse events were collected for 30 days postoperatively.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Prospective Group0/272 (0%)0/272 (0%)0/272 (0%)
Retrospective Arm0/1,597 (0%)0/1,597 (0%)0/1,597 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Prospective GroupRetrospective ArmTotal
Mean63.3 ± 12.465.7 ± 12.464.5 ± 12.4
Sex: Female, Male
Sex: Female, Male(Participants)Prospective GroupRetrospective ArmTotal
Female93518611
Male17910791258
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Prospective GroupRetrospective ArmTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Prospective GroupRetrospective ArmTotal
United States27215971869
08

Study locations

1 site
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 23, 2016

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02020018
Lead sponsor
Mayo Clinic
Collaborators
KCI USA, Inc
Responsible party
Hartzell V. Schaff (Professor of Surgery, Mayo Clinic) — Principal investigator
First posted
Dec 24, 2013
Start date
Oct 2013
Primary completion
Oct 2018
Completion
Oct 2018
Results posted
Nov 6, 2019
Last update
Nov 6, 2019

Study contacts

Hartzell V Schaff, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion